|
1
|
Rawla P, Sunkara T and Barsouk A:
Epidemiology of colorectal cancer: Incidence, mortality, survival,
and risk factors. Prz Gastroenterol. 14:89–103. 2019.PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morreale FE, Bortoluzzi A, Chaugule VK,
Arkinson C, Walden H and Ciulli A: Allosteric targeting of the
fanconi anemia ubiquitin-conjugating enzyme Ube2T by fragment
screening. J Med Chem. 60:4093–4098. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Alpi A, Langevin F, Mosedale G, Machida
YJ, Dutta A and Patel KJ: UBE2T, the Fanconi anemia core complex,
and FANCD2 are recruited independently to chromatin: A basis for
the regulation of FANCD2 monoubiquitination. Mol Cell Biol.
27:8421–8430. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu LL, Zhu JM, Yu XN, Zhu HR, Shi X,
Bilegsaikhan E, Guo HY, Wu J and Shen XZ: UBE2T promotes
proliferation via G2/M checkpoint in hepatocellular carcinoma.
Cancer Manag Res. 11:8359–8370. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alpi AF, Pace PE, Babu MM and Patel KJ:
Mechanistic insight into site-restricted monoubiquitination of
FANCD2 by Ube2t, FANCL, and FANCI. Mol Cell. 32:767–777. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hao J, Xu A, Xie X, Hao J, Tian T, Gao S,
Xiao X and He D: Elevated expression of UBE2T in lung cancer tumors
and cell lines. Tumour Biol. 29:195–203. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hao P, Kang B, Li Y, Hao W and Ma F: UBE2T
promotes proliferation and regulates PI3K/Akt signaling in renal
cell carcinoma. Mol Med Rep. 20:1212–1220. 2019.PubMed/NCBI
|
|
10
|
Liu LP, Yang M, Peng QZ, Li MY, Zhang YS,
Guo YH, Chen Y and Bao SY: UBE2T promotes hepatocellular carcinoma
cell growth via ubiquitination of p53. Biochem Biophys Res Commun.
493:20–27. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo C, Yao Y, Yu Z, Zhou H, Guo L, Zhang
J, Cao H, Zhang G, Li Y and Jiao Z: UBE2T knockdown inhibits
gastric cancer progression. Oncotarget. 8:32639–32654. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wen M, Kwon Y, Wang Y, Mao JH and Wei G:
Elevated expression of UBE2T exhibits oncogenic properties in human
prostate cancer. Oncotarget. 6:25226–25239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang DW, Sherman BT, Tan Q, Kir J, Liu D,
Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC and Lempicki RA:
DAVID bioinformatics resources: Expanded annotation database and
novel algorithms to better extract biology from large gene lists.
Nucleic Acids Res. 35:W169–W175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bader GD and Hogue CW: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi J, Zhong X, Song Y, Wu Z, Gao P, Zhao
J, Sun J, Wang J, Liu J and Wang Z: Long non-coding RNA RUNX1-IT1
plays a tumour-suppressive role in colorectal cancer by inhibiting
cell proliferation and migration. Cell Biochem Funct. 37:11–20.
2019. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chuang KC, Chen FW, Tsai MH and Shieh JJ:
EGR-1 plays a protective role in AMPK inhibitor compound C-induced
apoptosis through ROS-induced ERK activation in skin cancer cells.
Oncol Lett. 21:3042021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui F, Hu J, Ning S, Tan J and Tang H:
Overexpression of MCM10 promotes cell proliferation and predicts
poor prognosis in prostate cancer. Prostate. 78:1299–1310. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kelsall IR, Langenick J, MacKay C, Patel
KJ and Alpi AF: The Fanconi anaemia components UBE2T and FANCM are
functionally linked to nucleotide excision repair. PLoS One.
7:e369702012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rickman KA, Lach FP, Abhyankar A, Donovan
FX, Sanborn EM, Kennedy JA, Sougnez C, Gabriel SB, Elemento O,
Chandrasekharappa SC, et al: Deficiency of UBE2T, the E2 ubiquitin
ligase necessary for FANCD2 and FANCI ubiquitination, causes FA-T
subtype of fanconi anemia. Cell Rep. 12:35–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Seoane J: Cancer: Division hierarchy leads
to cell heterogeneity. Nature. 549:164–166. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao Z, Zhang H, Fan P, Huang Q, Dong K,
Qi Y, Song J, Chen L, Liang H, Chen X, et al: High PLK4 expression
promotes tumor progression and induces epithelial-mesenchymal
transition by regulating the Wnt/β-catenin signaling pathway in
colorectal cancer. Int J Oncol. 54:479–490. 2019.PubMed/NCBI
|
|
26
|
Raab M, Sanhaji M, Matthess Y, Hörlin A,
Lorenz I, Dötsch C, Habbe N, Waidmann O, Kurunci-Csacsko E,
Firestein R, et al: PLK1 has tumor-suppressive potential in
APC-truncated colon cancer cells. Nat Commun. 9:11062018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qian W, Zhang Z, Peng W, Li J, Gu Q, Ji D,
Wang Q, Zhang Y, Ji B, Wang S, et al: CDCA3 mediates p21-dependent
proliferation by regulating E2F1 expression in colorectal cancer.
Int J Oncol. 53:2021–2033. 2018.PubMed/NCBI
|
|
28
|
Nakayama KI and Nakayama K: Ubiquitin
ligases: Cell-cycle control and cancer. Nat Rev Cancer. 6:369–381.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang L, Jiang B, Zhu N, Tao M, Jun Y,
Chen X, Wang Q and Luo C: Mitotic checkpoint kinase Mps1/TTK
predicts prognosis of colon cancer patients and regulates tumor
proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt
pathway. Med Oncol. 37:52019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hu F, Gartenhaus RB, Eichberg D, Liu Z,
Fang HB and Rapoport AP: PBK/TOPK interacts with the DBD domain of
tumor suppressor p53 and modulates expression of transcriptional
targets including p21. Oncogene. 29:5464–5474. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang HQ, Zhao G, Ke B, Ma G, Liu GL,
Liang H, Liu LR and Hao XS: Overexpression of UBE2C correlates with
poor prognosis in gastric cancer patients. Eur Rev Med Pharmacol
Sci. 22:1665–1671. 2018.PubMed/NCBI
|
|
32
|
Dastsooz H, Cereda M, Donna D and Oliviero
S: A comprehensive bioinformatics analysis of UBE2C in cancers. Int
J Mol Sci. 20:22282019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen S, Yang J, Zhang Y, Duan C, Liu Q,
Huang Z, Xu Y, Zhou L and Xu G: Ubiquitin-conjugating enzyme UBE2O
regulates cellular clock function by promoting the degradation of
the transcription factor BMAL1. J Biol Chem. 293:11296–11309. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Voutsadakis IA: Ubiquitin- and
ubiquitin-like proteins-conjugating enzymes (E2s) in breast cancer.
Mol Biol Rep. 40:2019–2034. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hoeller D, Hecker CM and Dikic I:
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat
Rev Cancer. 6:776–788. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang W, Zhang Y, Yang Z, Liu X, Yang P,
Wang J, Hu K, He X, Zhang X and Jing H: High expression of UBE2T
predicts poor prognosis and survival in multiple myeloma. Cancer
Gene Ther. 26:347–355. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gong YQ, Peng D, Ning XH, Yang XY, Li XS,
Zhou LQ and Guo YL: UBE2T silencing suppresses proliferation and
induces cell cycle arrest and apoptosis in bladder cancer cells.
Oncol Lett. 12:4485–4492. 2016. View Article : Google Scholar : PubMed/NCBI
|
